Table 1.
Biopolymer type | Biopolymer | Sustainability credentials for biomedical applications | AM technique | Advantages | Disadvantages | Degradation time | Suggested polymers and bio-ceramics to develop composites | Formulations | Biomedical applications | Ref. |
---|---|---|---|---|---|---|---|---|---|---|
Natural | Chitosan | Biodegradable Low carbon footprint |
Extrusion, SLA | Non-immunogenicity, easily metabolized, antibacterial activity, and biocompatibility | Low mechanical strength, brittle, stiff | >20 weeks | HAp, BG, alginate, or collagen | Sponge, hydrogels, composite scaffolds | Gene delivery, wound dressing, bone, nervous, skin, liver, cardiovascular, and cartilage TE | [65], [66], [67] |
Alginate | Lower carbon footprint Biodegradable |
Extrusion | Non-immunogenicity, bioactivity, biocompatibility, and non-antigenicity | Limited toughness and mechanical strength | 80 d | BG, HAp, chitosan, or PLA | Micro/nanosphere, hydrogels | Hollow vascular channels, bone, cartilage, neural, skin regeneration, and wound healing | [68], [69], [70] | |
Cellulose | Excellent biodegradability Low carbon footprint |
DIW, FDM, IJP | Bioactivity, excellent mechanical characteristics, and biocompatibility | Limited cell adhesion | Weeks to months | HAp, CNTs, chitosan, PLA, or PBS | Composite scaffolds | Neural, skin, tendons, muscle, cardiac, cartilage, and bone regeneration | [71], [72], [73], [74] | |
Collagen | Biodegradable Low embodied energy level and carbon footprint |
Extrusion, IJP | High porosity, bioactivity, excellent mechanical characteristics, biocompatibility, and poor immunogenicity | Low antigenicity, low mechanical strength, and low stiffness | 12 h | HA, PLGA, BG, or HAp | Scaffolds | Drug delivery, vascular, dental, cornea, bone, cartilage, and artificial skin regeneration | [75], [76], [77] | |
SF | Excellent biodegradability Low carbon footprint |
Micro-extrusion, SLA, IJP | Biocompatibility, excellent mechanical characteristics, high tensile strength, bioactivity, high flexibility, and low immunogenicity | Brittle, rapidly degrade | 6 weeks | Collagen, HAp, PLA, or calcium phosphate | Scaffolds | Gene delivery, wound healing, hepatic, vascular, cornea, neural, tendon, bone, cartilage, and skin regeneration | [78], [79], [80], [81] | |
Gelatin | Biodegradable Low embodied energy level |
Extrusion, SLA | Biocompatibility, bioactivity, ECM mimicked, poor immunogenicity, and better solubility | Rapid degradation, low mechanical strength, limited solubility in concentrated solutions | 10 d | Chitosan, HAp, PLA, or PCL | Micro/nanosphere, hydrogels | Aortic valves, neovascularization, cartilage, neural, bone, and skin regeneration | [82], [83], [84] | |
Starch | Excellent biodegradability Low carbon footprint |
Extrusion | Non-toxicity and biocompatibility | Brittle and less surface area | Several weeks | GO, BG, or PCL | Composite scaffolds | bone, skin regeneration, and drug delivery systems | [85], [86], [87], [88] | |
HA | Biodegradable Low embodied energy level |
Extrusion | Non-toxicity, easily modified through chemical reaction, and biocompatibility | Fast degradation rate and low mechanical characteristics | 4 months | PEG, PLA, PLGA, collagen, or chitosan | Scaffolds, hydrogels | Skin and neural regeneration | [89], [90], [91] | |
Synthetic | PLA | PLA degradation within the human body PLA copolymers, which can help in the adjustment of degradation |
Extrusion, SLA, IJP | Highly flexible and biocompatible | Highly inflammable, low cellular adhesion, porosity and bioactivity, poor rate of degradation | 20 months | HA, alginate, chitosan, PCL, HAp, or BG | Hydrogels, composite scaffolds | Suture, neural, bone, skin cartilage, cardiovascular, ligament regeneration, and drug delivery applications | [92], [93], [94] |
PCL | Slow degradation rate Water, solvent, oil, and chlorine resistant |
Extrusion, SLA, IJP | Highly flexible, excellent mechanical characteristics, degradation and solubility, biocompatible, and minimal inflammability | Limited degradation and low cell adhesion | 6–28 months | Chitosan, PLA, BG, or HAp | Composite scaffolds, hydrogels | Dentistry, vascular, bone, retina, skin regeneration, and pharmaceutical applications | [95], [96], [97] | |
PGA | Insoluble in water Biodegradable |
Extrusion, SLA, IJP | Excellent tensile strength, bioresorbable, and biocompatible | Limited solubility and rapid degradation | 5 months | PLA, PEG, PLGA, collagen, or chitosan | Composite scaffolds, hydrogels | Surgical sutures, bone, ligament, and cartilage reconstruction | [98], [99], [100], [101] | |
PHB | Biodegradable | Extrusion, IJP | Excellent mechanical, barrier properties, piezoelectricity, and optical activity | Limited solubility, and low cell adhesion | 6–10 months | Chitosan or alginate | Composite scaffolds, hydrogels | Surgical implants, biomedical devices, bone, skin, cartilage regeneration, or breast augmentation | [102], [103], [104] | |
PVA | Biodegradable Low carbon footprint |
Extrusion, IJP | Biocompatibility, non-toxicity, self-healing property, and hydrophilicity | Low cell adhesion | 16–25 d | Gelatin, chitosan, PLA, or PGA | Hydrogels, composite scaffolds | Drug delivery, wound dressing, bone, cartilage, and skin regeneration | [105], [106], [107] |